Alacramed was formed as a spin-out from leading lifescience consultancy Alacrita in October 2015. Spinning out a separate business was a strategic move to enhance focus on medical devices and better serve Alacrita’s growing number of medical device clients. We understood that medtech often has diverse and very different challenges to biopharma and that to meet these challenges and provide the best possible service for clients required a dedicated consultancy with its own network of industry experts and capabilities.
We believe that using seasoned industry experts in our project teams plays an essential part in delivering real value to our clients. We hand-pick genuine experts to form tailored teams and work with them to understand and address the challenges that our clients are facing. Many of our experts have over twenty years of sector and specialist experience gained in both large and small companies working both sides of the Atlantic.
This transatlantic dimension allows us to help US based clients access European markets and European clients access US markets.Our network of consultants goes beyond our core team and is extensive. In addition to broad functional coverage from general management through to R&D, marketing, intellectual property, market access, regulatory and quality it also covers all of the main medtech sectors including orthopaedics, cardiology, diagnostics, drug delivery, ophthalmic and dental.
Our services include: business planning; business development; technical and commercial due diligence; regulatory strategy and filings; market access; quality auditing; operations; intellectual property; market research and assessment; product design and development. In essence we provide the full range of services required to commercialise medical technologies and create real value for our clients.